The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 9th 2025
New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.
Could Pharmacogenetic Dosing Reduce Warfarin-Related Adverse Events?
March 20th 2017Personalizing doses of warfarin through genetic testing helped reduce the risk of combined adverse events in patients undergoing elective orthopedic surgery, according to data presented at the American College of Cardiology's 66th Annual Scientific Session.
Read More
Omega-3 Fish Oil: Insufficient Evidence of Heart Disease Prevention
March 20th 2017The American Heart Association (AHA) has published a new science advisory stating that there is not enough evidence to support the use of fish oil supplementation as a primary prevention of cardiovascular disease in the general population.
Read More
Study Examines Relationship Between Opioid Use and Cancer Progression
March 18th 2017A study led by UC Irvine and Duke University, presented at the 2017 American Academy of Pain Medicine meeting in Orlando, examined the association between opioid therapy and melanoma progression in patients diagnosed with the disease.
Read More
Publix and BayCare Health System Announce Exclusive Four-County Collaboration
March 17th 2017Publix Pharmacy and BayCare Health System have announced an exclusive collaboration to improve the delivery of health care to the residents of Hillsborough, Pasco, Pinellas, and Polk counties in Florida.
Read More
Survey: Naloxone Successful at Reversing Overdoses in Most Cases
March 17th 2017At the American Academy of Pain Medicine’s 2017 Annual Meeting, survey results were presented that revealed the implications of naloxone use in real-world experiences with the recently approved intranasal naloxone formulation.
Read More
Three Dietary Supplement Manufacturers Ordered to Halt Operations
March 14th 2017Officials with the FDA noted that in past inspections, dating back as far as 2012, they have noticed the dietary supplement products were misbranded because they were being marketed with drug claims despite not being approved for any use.
Read More